Clinical trial
Metformin as an Adjunctive Therapy For Transient Hyperglycemia in Patients With Acute Lymphoblastic Leukemia During Induction Chemotherapy
NCT01486043 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin as an Adjunctive Therapy For Transient Hyperglycemia in Patients With Acute Lymphoblastic Leukemia During Induction Chemotherapy
- Lead sponsor
- Children's Hospital Los Angeles
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 31, 2011
- Completion date
- May 31, 2013
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, diabetes mellitus, hyperglycemia, insulin resistance